Phathom Pharmaceuticals Inc. (PHAT) NASDAQ
$8.99 (0.49) (-5.17%)
Market Cap: $554.81M
As of 04/19/24 03:11 PM EDT. Market open.
Phathom Pharmaceuticals Inc. (PHAT)
NASDAQ
$8.99
(0.49) (-5.17%)
Market Cap: $554.81M
As of 04/19/24 03:11 PM EDT. Market open.
Add to Portfolio
phathom pharmaceuticals, inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. the company has the rights in the united states, europe, and canada to vonoprazan, a potassium-competitive acid blocker (p-cab) that blocks acid secretion in the stomach. it is also developing vonoprazan, which is in phase iii clinical ... read more
phathom pharmaceuticals, inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. the company has the rights in the united states, europe, and canada to vonoprazan, a potassium-competitive acid blocker (p-cab) that blocks acid secretion in the stomach. it is also developing vonoprazan, which is in phase iii clinical trials for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of helicobacter pylori infection. the company was incorporated in 2018 and is based in buffalo grove, illinois. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
Full Time Employees
105
Address
.
PRICE CHART FOR PHATHOM PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$9.42
Previous Close
$9.48
Days Range
$9.46 - $9.80
52 week range
$6.07 - $17.02
Volume
388,937
Avg. Volume (30 days)
874,504
Market Cap
$554.81M
Dividend Yield
-
P/E
-
Shares Outstanding
58,524,101
Open
$9.42
Previous Close
$9.48
Days Range
$9.46 - $9.80
52 week range
$6.07 - $17.02
Volume
388,937
Avg. Volume (30 days)
874,504
Market Cap
$554.81M
Dividend Yield
-
P/E
-
Shares Outstanding
58,524,101
FINANCIAL STATEMENTS FOR PHATHOM PHARMACEUTICALS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR PHATHOM PHARMACEUTICALS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Henderson Molly | CFO and CBO | Apr 08, 2024 | Sale | $11.10 | 3,435 | 38,129 | 95,263 | Apr 10, 2024, 04:30 PM |
| Curran Terrie | President and Chief Executive | Mar 22, 2024 | Sale | $9.11 | 16,851 | 153,513 | 410,784 | Mar 26, 2024, 04:05 PM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Jan 24, 2024 | Sale | $8.10 | 3,703,703 | 29,999,996 | 3,755,583 | Jan 25, 2024, 06:13 AM |
| Henderson Molly | CFO and CBO | Jan 19, 2024 | Sale | $7.75 | 6,307 | 48,900 | 98,698 | Jan 22, 2024, 08:22 PM |
| Henderson Molly | CFO and CBO | Nov 20, 2023 | Sale | $7.24 | 2,127 | 15,403 | 103,061 | Nov 21, 2023, 04:40 PM |
| Parikh Asit | Director | Nov 08, 2023 | Buy | $7.80 | 2,500 | 19,500 | 55,000 | Nov 08, 2023, 07:56 PM |
| Parikh Asit | Director | Nov 07, 2023 | Buy | $7.76 | 4,000 | 31,040 | 52,500 | Nov 08, 2023, 07:56 PM |
| Parikh Asit | Director | Nov 06, 2023 | Buy | $8.04 | 1,000 | 8,040 | 48,500 | Nov 08, 2023, 07:56 PM |
| Henderson Molly | CFO and CBO | Nov 01, 2023 | Sale | $8.88 | 12,492 | 110,871 | 116,869 | Nov 03, 2023, 04:55 PM |
| Henderson Molly | CFO and CBO | Jul 14, 2023 | Option Exercise | $1.00 | 25,000 | 25,000 | 95,180 | Jul 17, 2023, 05:00 PM |
| Parikh Asit | Director | Jun 02, 2023 | Option Exercise | $7.40 | 15,000 | 111,000 | 47,500 | Jun 05, 2023, 06:37 PM |
| Henderson Molly | CFO and CBO | Jun 02, 2023 | Sale | $11.41 | 1,960 | 22,368 | 68,506 | Jun 05, 2023, 06:32 PM |
| Henderson Molly | CFO and CBO | May 22, 2023 | Sale | $12.87 | 2,110 | 27,165 | 70,466 | May 23, 2023, 12:15 PM |
| Parikh Asit | Director | Apr 10, 2023 | Buy | $7.55 | 1,000 | 7,550 | 23,500 | Apr 11, 2023, 04:05 PM |
| Nabulsi Azmi | Chief Operating Officer | Apr 11, 2023 | Buy | $8.26 | 10,000 | 82,600 | 99,567 | Apr 11, 2023, 04:05 PM |
| Curran Terrie | President and Chief Executive | Apr 06, 2023 | Buy | $7.82 | 12,919 | 101,025 | 188,290 | Apr 07, 2023, 03:19 PM |
| Henderson Molly | CFO and CBO | Apr 06, 2023 | Sale | $7.27 | 3,439 | 25,002 | 72,576 | Apr 07, 2023, 03:18 PM |
| Henderson Molly | CFO and CBO | Mar 01, 2023 | Sale | $8.53 | 2,032 | 17,335 | 76,015 | Mar 03, 2023, 07:03 PM |
| Curran Terrie | President and Chief Executive | Mar 01, 2023 | Sale | $8.54 | 1,436 | 12,265 | 175,371 | Mar 03, 2023, 06:59 PM |
| Parikh Asit | Director | Feb 13, 2023 | Buy | $7.73 | 5,000 | 38,660 | 22,500 | Feb 14, 2023, 04:56 PM |
| Curran Terrie | President and Chief Executive | Jan 20, 2023 | Sale | $8.20 | 5,821 | 47,729 | 176,807 | Jan 20, 2023, 07:39 PM |
| Parikh Asit | Director | Jan 12, 2023 | Buy | $7.00 | 5,000 | 35,000 | 17,500 | Jan 12, 2023, 04:32 PM |
| Henderson Molly | CFO and CBO | Nov 21, 2022 | Sale | $9.60 | 2,159 | 20,726 | 43,341 | Nov 23, 2022, 04:10 PM |
| Curran Terrie | President and Chief Executive | Nov 21, 2022 | Sale | $9.60 | 1,526 | 14,650 | 83,720 | Nov 23, 2022, 04:07 PM |
| Nabulsi Azmi | Chief Operating Officer | May 16, 2022 | Buy | $8.16 | 20,000 | 163,288 | 785,700 | May 16, 2022, 08:48 PM |
| Curran Terrie | President and Chief Executive | May 13, 2022 | Buy | $7.41 | 20,500 | 151,835 | 64,595 | May 16, 2022, 08:45 PM |
| Parikh Asit | Director | May 12, 2022 | Buy | $8.00 | 12,500 | 100,000 | 12,500 | May 16, 2022, 08:39 PM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Mar 14, 2022 | Sale | $19.00 | 18 | 342 | 7,459,286 | Mar 16, 2022, 08:10 PM |
| COLA MICHAEL F | Director | Oct 29, 2019 | Buy | $19.00 | 9,798 | 186,162 | 9,798 | Feb 18, 2022, 07:34 PM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Nov 04, 2021 | Sale | $20.85 | 1,000,001 | 20,850,019 | 1,100,000 | Nov 08, 2021, 06:04 AM |
| Socks David A | Director | Oct 08, 2021 | Sale | $32.05 | 2,529 | 81,052 | 1,211,346 | Oct 08, 2021, 06:28 PM |
| Socks David A | Director | Oct 07, 2021 | Sale | $32.66 | 15,471 | 505,343 | 1,213,875 | Oct 08, 2021, 06:28 PM |
| Socks David A | Director | Sep 22, 2021 | Sale | $32.06 | 4,100 | 131,446 | 1,229,346 | Sep 23, 2021, 08:37 PM |
| Socks David A | Director | Sep 21, 2021 | Sale | $32.80 | 13,900 | 455,905 | 1,233,770 | Sep 23, 2021, 08:37 PM |
| Socks David A | Director | Aug 16, 2021 | Sale | $31.25 | 18,000 | 562,538 | 1,261,137 | Aug 18, 2021, 05:31 PM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Jul 07, 2021 | Sale | $35.05 | 2,609 | 91,445 | 871,305 | Jul 09, 2021, 06:09 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Jul 02, 2021 | Sale | $35.01 | 100 | 3,501 | 873,914 | Jul 06, 2021, 06:10 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Jul 01, 2021 | Sale | $35.16 | 8,226 | 289,226 | 874,014 | Jul 06, 2021, 06:10 AM |
| Socks David A | Director | Jun 29, 2021 | Sale | $34.00 | 13,960 | 474,657 | 1,260,945 | Jun 29, 2021, 08:43 PM |
| Socks David A | Director | Jun 28, 2021 | Sale | $34.07 | 26,040 | 887,284 | 1,275,061 | Jun 29, 2021, 08:43 PM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Jun 28, 2021 | Sale | $35.08 | 370 | 12,980 | 882,240 | Jun 29, 2021, 06:44 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Jun 25, 2021 | Sale | $35.49 | 24,131 | 856,448 | 883,860 | Jun 29, 2021, 06:44 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Jun 23, 2021 | Sale | $35.00 | 200 | 7,000 | 917,589 | Jun 25, 2021, 07:27 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Jun 24, 2021 | Sale | $35.14 | 10,848 | 381,199 | 906,741 | Jun 25, 2021, 07:27 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Jun 22, 2021 | Sale | $35.00 | 100 | 3,500 | 917,789 | Jun 23, 2021, 06:15 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Jun 21, 2021 | Sale | $35.31 | 9,294 | 328,171 | 917,889 | Jun 23, 2021, 06:15 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Jun 14, 2021 | Sale | $35.06 | 2,826 | 99,080 | 935,886 | Jun 16, 2021, 06:06 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Jun 08, 2021 | Sale | $35.00 | 100 | 3,500 | 942,005 | Jun 09, 2021, 06:41 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Jun 07, 2021 | Sale | $35.05 | 2,264 | 79,353 | 942,105 | Jun 09, 2021, 06:41 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Jun 02, 2021 | Sale | $35.18 | 4,300 | 151,274 | 944,369 | Jun 04, 2021, 06:23 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Jun 01, 2021 | Sale | $35.78 | 11,211 | 401,130 | 952,636 | Jun 02, 2021, 06:08 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | May 28, 2021 | Sale | $36.19 | 8,905 | 322,305 | 964,652 | Jun 02, 2021, 06:08 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | May 27, 2021 | Sale | $37.14 | 8,453 | 313,953 | 971,064 | May 28, 2021, 06:11 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | May 26, 2021 | Sale | $36.64 | 12,358 | 452,747 | 982,127 | May 28, 2021, 06:11 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | May 25, 2021 | Sale | $36.18 | 10,947 | 396,079 | 990,144 | May 26, 2021, 09:42 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | May 24, 2021 | Sale | $35.66 | 10,594 | 377,810 | 1,002,226 | May 26, 2021, 09:42 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | May 21, 2021 | Sale | $35.74 | 11,648 | 416,300 | 1,011,137 | May 24, 2021, 06:24 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | May 20, 2021 | Sale | $35.10 | 7,098 | 249,140 | 1,022,785 | May 24, 2021, 06:24 AM |
| Socks David A | Director | May 20, 2021 | Sale | $34.66 | 3,482 | 120,687 | 1,303,528 | May 21, 2021, 06:13 PM |
| Socks David A | Director | May 19, 2021 | Sale | $32.44 | 36,518 | 1,184,819 | 1,323,676 | May 21, 2021, 06:13 PM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | May 14, 2021 | Sale | $35.00 | 100 | 3,500 | 1,029,883 | May 18, 2021, 06:02 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | May 12, 2021 | Sale | $35.44 | 11,776 | 417,359 | 1,030,988 | May 14, 2021, 06:04 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | May 13, 2021 | Sale | $35.33 | 100 | 3,533 | 1,029,983 | May 14, 2021, 06:04 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | May 07, 2021 | Sale | $35.03 | 1,011 | 35,415 | 1,041,859 | May 11, 2021, 06:30 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | May 06, 2021 | Sale | $35.01 | 202 | 7,072 | 1,042,870 | May 07, 2021, 07:22 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | May 05, 2021 | Sale | $35.14 | 6,936 | 243,731 | 1,043,072 | May 07, 2021, 07:22 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | May 04, 2021 | Sale | $36.04 | 19,360 | 697,808 | 1,058,298 | May 05, 2021, 08:26 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | May 03, 2021 | Sale | $38.28 | 14,632 | 560,041 | 1,080,843 | May 05, 2021, 08:26 AM |
| Nabulsi Azmi | Chief Operating Officer | May 04, 2021 | Sale | $36.86 | 4,457 | 164,302 | 768,189 | May 04, 2021, 08:31 PM |
| Nabulsi Azmi | Chief Operating Officer | May 03, 2021 | Sale | $38.27 | 10,043 | 384,354 | 775,910 | May 04, 2021, 08:31 PM |
| Nabulsi Azmi | Chief Operating Officer | Apr 05, 2021 | Sale | $36.11 | 9,353 | 337,733 | 785,301 | Apr 05, 2021, 07:01 PM |
| Nabulsi Azmi | Chief Operating Officer | Apr 01, 2021 | Sale | $37.57 | 5,147 | 193,369 | 791,295 | Apr 05, 2021, 07:01 PM |
| Curran Terrie | President and Chief Executive | Mar 22, 2021 | Option Exercise | $6.95 | 11,513 | 80,015 | 11,513 | Mar 23, 2021, 07:22 PM |
| Curran Terrie | President and Chief Executive | Mar 22, 2021 | Sale | $43.32 | 11,513 | 498,751 | 1,140 | Mar 23, 2021, 07:22 PM |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Mar 11, 2021 | Sale | $43.75 | 710,000 | 31,062,500 | 3,115,008 | Mar 15, 2021, 04:36 PM |
| Socks David A | Director | Mar 12, 2021 | Sale | $46.67 | 500 | 23,335 | 1,380,945 | Mar 12, 2021, 05:54 PM |
| Socks David A | Director | Mar 11, 2021 | Sale | $47.19 | 42,429 | 2,002,099 | 1,382,176 | Mar 12, 2021, 05:54 PM |
| Socks David A | Director | Mar 10, 2021 | Sale | $49.01 | 12,071 | 591,657 | 1,433,520 | Mar 12, 2021, 05:54 PM |
| Nabulsi Azmi | Chief Operating Officer | Mar 02, 2021 | Sale | $45.90 | 9,127 | 418,928 | 803,227 | Mar 03, 2021, 08:20 PM |
| Nabulsi Azmi | Chief Operating Officer | Mar 01, 2021 | Sale | $45.85 | 5,373 | 246,362 | 805,375 | Mar 03, 2021, 08:20 PM |
| Socks David A | Director | Feb 22, 2021 | Sale | $45.66 | 20,140 | 919,587 | 1,449,587 | Feb 23, 2021, 06:14 PM |
| Socks David A | Director | Feb 19, 2021 | Sale | $47.18 | 44,876 | 2,117,034 | 1,500,745 | Feb 23, 2021, 06:14 PM |
| Socks David A | Director | Feb 23, 2021 | Sale | $43.74 | 4,984 | 217,991 | 1,439,910 | Feb 23, 2021, 06:14 PM |
| Nabulsi Azmi | Chief Operating Officer | Feb 02, 2021 | Sale | $40.97 | 9,084 | 372,156 | 815,584 | Feb 03, 2021, 04:05 PM |
| Nabulsi Azmi | Chief Operating Officer | Feb 01, 2021 | Sale | $38.09 | 5,416 | 206,285 | 818,284 | Feb 03, 2021, 04:05 PM |
| Socks David A | Director | Jan 12, 2021 | Sale | $36.07 | 27,165 | 979,795 | 1,553,036 | Jan 13, 2021, 05:07 PM |
| Socks David A | Director | Jan 11, 2021 | Sale | $34.92 | 12,835 | 448,243 | 1,560,110 | Jan 13, 2021, 05:07 PM |
| Nabulsi Azmi | Chief Operating Officer | Jan 04, 2020 | Sale | $33.58 | 12,646 | 424,666 | 833,268 | Jan 05, 2021, 07:17 PM |
| Nabulsi Azmi | Chief Operating Officer | Jan 05, 2020 | Sale | $33.77 | 1,854 | 62,608 | 823,700 | Jan 05, 2021, 07:17 PM |
| Socks David A | Director | Dec 17, 2020 | Sale | $40.74 | 48,212 | 1,964,376 | 1,585,960 | Dec 18, 2020, 08:01 PM |
| Socks David A | Director | Dec 16, 2020 | Sale | $47.53 | 31,446 | 1,494,519 | 1,647,603 | Dec 18, 2020, 08:01 PM |
| Nabulsi Azmi | Chief Operating Officer | Dec 02, 2020 | Sale | $45.26 | 7,302 | 330,512 | 841,195 | Dec 03, 2020, 06:01 PM |
| Nabulsi Azmi | Chief Operating Officer | Dec 01, 2020 | Sale | $44.20 | 7,198 | 318,176 | 847,330 | Dec 03, 2020, 06:01 PM |
| Socks David A | Director | Nov 10, 2020 | Sale | $41.69 | 12,681 | 528,672 | 1,668,682 | Nov 12, 2020, 04:13 PM |
| Socks David A | Director | Nov 09, 2020 | Sale | $42.33 | 10,784 | 456,506 | 1,682,139 | Nov 12, 2020, 04:13 PM |
| Socks David A | Director | Nov 11, 2020 | Sale | $38.97 | 6,877 | 268,021 | 1,656,860 | Nov 12, 2020, 04:13 PM |
| Nabulsi Azmi | Chief Operating Officer | Nov 02, 2020 | Sale | $36.83 | 14,500 | 534,026 | 852,700 | Nov 03, 2020, 06:40 PM |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Apr 01, 2020 | Buy | $24.86 | 117,600 | 2,923,642 | 3,825,008 | Apr 03, 2020, 04:30 PM |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Mar 31, 2020 | Buy | $24.55 | 30,600 | 751,264 | 3,707,408 | Mar 31, 2020, 05:02 PM |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Mar 27, 2020 | Buy | $24.60 | 30,000 | 738,000 | 3,676,808 | Mar 31, 2020, 05:02 PM |
| Edwards Jonathan S. | Director | Oct 29, 2019 | Option Exercise | $15.20 | 23,558 | 358,082 | 23,558 | Oct 30, 2019, 05:05 PM |
| Edwards Jonathan S. | Director | Oct 29, 2019 | Option Exercise | $15.20 | 991,672 | 15,073,414 | 991,672 | Oct 30, 2019, 05:05 PM |
| Edwards Jonathan S. | Director | Oct 29, 2019 | Buy | $19.00 | 24,426 | 464,094 | 47,984 | Oct 30, 2019, 05:05 PM |
| Edwards Jonathan S. | Director | Oct 29, 2019 | Buy | $19.00 | 1,028,205 | 19,535,895 | 2,019,877 | Oct 30, 2019, 05:05 PM |
| Frazier Life Sciences IX, L.P. | 10% Owner | Oct 29, 2019 | Option Exercise | $15.20 | 1,353,640 | 20,575,328 | 6,231,638 | Oct 30, 2019, 05:04 PM |
| Frazier Life Sciences IX, L.P. | 10% Owner | Oct 29, 2019 | Buy | $19.00 | 1,052,631 | 19,999,989 | 7,284,269 | Oct 30, 2019, 05:04 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
FUNDS WITH A POSITION IN PHATHOM PHARMACEUTICALS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 2,678,891 | 0.00062% | 9.89% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 735,273 | 0.0007% | 7.72% | Other |
| D. E. SHAW & CO., INC. | 129,389 | 0.00103% | -0.9% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 65,600 | 0.00093% | New | Other |
| UBS OCONNOR LLC | 43,209 | 0.03% | -63.16% | Value |
| AQR CAPITAL MANAGEMENT LLC | 18,427 | 0.00032% | -19.3% | Other |
CHANGE IN SHARES OUTSTANDING FOR PHATHOM PHARMACEUTICALS INC
STOCK BUYBACKS FOR PHATHOM PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
1.02%
1Q
06/30/2023
18.27%
2Q
03/31/2023
35.43%
3Q
12/31/2022
38.77%
4Q
09/30/2022
47.76%
5Q
06/30/2022
49.88%
6Q
03/31/2022
50.80%
7Q
12/31/2021
51.88%
8Q
09/30/2021
53.78%
9Q
06/30/2021
56.57%
10Q
03/31/2021
58.02%
11Q
12/31/2020
68.34%
12Q
09/30/2020
71.91%
13Q
06/30/2020
73.83%
14Q
03/31/2020
76.65%
15Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR PHATHOM PHARMACEUTICALS INC
LOADING...